ELDN - Eledon Pharmaceuticals Business Value
The price action for Eledon Pharmaceuticals (ELDN) reflects an enterprise value of 175.01, driven by strict temperature control during biomaterial transport and adherence to laboratory safety standards without the use of manufacturing plants. The business relies on developing anti-organ rejection agents, focusing on blocking the CD40L pathway to minimize therapy toxicity across B2B and B2C segments.
%20Total%20Company%20Value&width=1200&height=400&colorIndex=0&v=mvt4kixj.9g-7avve2o&start=20220704&end=20261029&filename=GURU_Markets_-_ELDN_-_Eledon-Pharmaceuticals_-_Total-Company-Value "ELDN Eledon Pharmaceuticals, Inc.: Business Value in the range 11/23/2025 - 10/29/2026 | 👁️GURU.Markets👁️")
Eledon Pharmaceuticals (ELDN) - metric breakdowns and financial figures
- stock price and consensus target price:
- market capitalization statistics:
- balance sheet net asset value indicators:
- debt level and financial liquidity data:
All Debt to Shareholders' Equity Ratio Eledon Pharmaceuticals|ELDN - Long-Term Debt to Capital|Short-Term Debt to Capital eledon.com|ELDN - Company Debts|Debt to Net Assets Ratio Eledon Pharmaceuticals|ELDN - Company Long-Term Debt|Company Current Liabilities Eledon Pharmaceuticals|Quick Ratio eledon.com
- earnings and valuation multiples indicators:
Analysis of all company metrics:Eledon Pharmaceuticals Inc.
Enterprise value is calculated as the sum of market capitalization and net debt, reflecting the total cost of acquiring the business inclusive of all liabilities and liquid assets. For Eledon Pharmaceuticals (ELDN), the enterprise value reflects a speculative valuation currently based on clinical trial expectations for its antibody rather than current operating revenues.
Competitors of Eledon Pharmaceuticals (ELDN)
argenx N.V. - Total Company Value|BioNTech Group - Enterprise Value|ABVX (Abivax Pharma) - Business Value|ADMA Biologics (ADMA) - Total Company Value|Business Value PTGX|Total Company Value Immunovant|Kiniksa Pharmaceuticals, Ltd. - Full Business Value|Enterprise Value GRFS|ADPT (Adaptive Biotechnologies Inc.) - Value Adjusted for Debt and Cash|Enterprise Value CLDX (Celldex Therapeutics)|Enterprise Value auriniapharma.com AUPH|BCRX - Total Company Value|Value Adjusted for Debt and Cash VERA (Vera Therapeutics Inc)|Dianthus Pharma (DNTH) - Total Company Value|Real Price to Acquire Entire Company Pharvaris Pharma|ABCL (AbCellera Biologics Inc) - Enterprise Value|Enterprise Value tourmalinebio.com|Real Price to Acquire Entire Company PGEN (Precigen)|PHAR (Pharming Group NV) - Value Adjusted for Debt and Cash|Enterprise Value NKTR (Nektar)|Company Buyout Price Upstream Pharma (UPB)|ZBIO - Total Company Value|immunome.com (IMNM) - Real Price to Acquire Entire Company|Gossamer Bio (GOSS) - Total Company Value|Real Price to Acquire Entire Company KalVista Pharma|Real Price to Acquire Entire Company SEPN|Enterprise Value Pieris Corp|Total Company Value Savara Inc. (SVRA)|rigel.com - Business Value|Enterprise Value ANAB (AnaptysBio)|Astria Therapeutics Inc (ATXS) - Total Enterprise Value|enGene Bio - Enterprise Value|Total Enterprise Value RAPT Therapeutics Inc.|aerovatetx.com (JBIO) - Total Company Value|ACRS (aclaristx.com) - Total Company Value|KYTX (Kyverna Therapeutics, Inc.) - Enterprise Value|Total Enterprise Value Tiziana Life Sciences Ltd. TLSA|Enterprise Value CABA|Ventyx Biosciences, Inc - Business Value|Total Company Value Theratechnologies Inc. THTX|avalotx.com (AVTX) - Total Enterprise Value|AGEN - Total Company Value|CLYM (Climb Bio Inc.) - Business Value|ZURA (Zura Bio) - Real Price to Acquire Entire Company|aTyr Pharmaceuticals - Value Adjusted for Debt and Cash|Total Company Value Adagene Inc|Ikena Oncology, Inc. - Full Business Value|Enterprise Value STTK|EQ (equilliumbio.com) - Value Adjusted for Debt and Cash|Enterprise Value CNTB (Connect Biopharma Holdings Limited)|Enterprise Value Immunic Therapeutics IMUX|ATRA - Total Company Value|Value Adjusted for Debt and Cash IFRX (InflaRx N.V.)|X4 Pharmaceuticals, Inc. (XFOR) - Total Company Value|Real Price to Acquire Entire Company Adicet Bio, Inc.|CELU (Celularity Inc) - Enterprise Value|Enterprise Value INmune Bio Corporation|Enterprise Value BRNS|Real Price to Acquire Entire Company kezarlifesciences.com KZR|Enterprise Value SABS (SAB Biotherapeutics, Inc.)|Akari Therapeutics PLC (AKTX) - Total Enterprise Value|ENLV: Real Price to Acquire Entire Company|QTTB - Enterprise Value|GOVX (GeoVax Labs, Inc.) - Real Price to Acquire Entire Company|EDSA: Aggregate Business Value|IBIO (iBio) - Enterprise Value|Carisma Tx (CARM) - Company Buyout Price|Enterprise Value XTLB|Real Price to Acquire Entire Company boltbio.com BOLT|Enterprise Value HCWB (HCW Biologics)|Enterprise Value Aptevo Therapeutics, Inc. APVO|AIM - Total Company Value|ADTX: Total Company Value|GRI Bio Corp (GRI) - Total Company Value|XRTX - Company Buyout Price|HIND (Vyome Holdings Inc) - Enterprise Value|Total Enterprise Value revbiosciences.com REVB|Total Company Value Indaptus Therapeutics, Inc. (INDP)|Total Company Value SCNI (Scinai Immunotherapeutics Ltd)|Enterprise Value CALI (CalciMedica)|AFMD: Business Value|ALLK - Total Company Value|HOOK (HOOKIPA Pharma Inc.) - Business Value|igmbio.com (IGMS) - Total Company Value|Full Business Value ITOS (iTeos Therapeutics Inc)|OCEA (Ocean Bio) - Enterprise Value|TCBP: Value Adjusted for Debt and Cash|Enterprise Value THRD